Difference between revisions of "Leucovorin (Folinic acid)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m (Jwarner moved page Folinic acid (Leucovorin) to Leucovorin (Folinic acid): Alignment with INN)
 
(11 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
==General information==
 
==General information==
Class/mechanism: Folic acid analog; counteracts the effects of folic acid antagonists such as methotrexate, which acts by inhibiting dihydrofolate reductase. Enhances the activity of [[Fluorouracil (5-FU)]] by inhibiting thymidylate synthase.<ref name="insert">[https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208723s000lbl.pdf Folinic acid (Leucovorin) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/folinicacid.pdf Folinic acid (Leucovorin) package insert (locally hosted backup)]</ref>
+
Class/mechanism: Folic acid analog; counteracts the effects of folic acid antagonists such as methotrexate, which acts by inhibiting dihydrofolate reductase. Enhances the activity of [[Fluorouracil (5-FU)]] by inhibiting thymidylate synthase.<ref name="insert">[https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208723s000lbl.pdf Leucovorin (Folinic acid) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/folinicacid.pdf Leucovorin (Folinic acid) package insert (locally hosted backup)]</ref>
 
<br>Route: PO, IM, IV
 
<br>Route: PO, IM, IV
 
<br>Extravasation: no information  
 
<br>Extravasation: no information  
  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>  
 +
 +
==Diseases for which it is established ''(work in progress)''==
 +
''Note: these are diseases where folinic acid is used as an adjuvant to [[Fluorouracil (5-FU)]], as opposed to an antidote as it is used in conjunction with [[Methotrexate (MTX)]]''
 +
*[[Colorectal cancer]]
 +
**[[Colon cancer]]‎
 +
**[[Rectal cancer]]
 +
*[[Hepatocellular carcinoma]]
  
 
==Diseases for which it is used==
 
==Diseases for which it is used==
 
''Note: these are diseases where folinic acid is used as an adjuvant to [[Fluorouracil (5-FU)]], as opposed to an antidote as it is used in conjunction with [[Methotrexate (MTX)]]''
 
''Note: these are diseases where folinic acid is used as an adjuvant to [[Fluorouracil (5-FU)]], as opposed to an antidote as it is used in conjunction with [[Methotrexate (MTX)]]''
  
 +
*[[Anal cancer]]
 
*[[Cervical cancer]] ‎  
 
*[[Cervical cancer]] ‎  
 
*[[Cholangiocarcinoma]]
 
*[[Cholangiocarcinoma]]
*[[Colorectal cancer]]
 
**[[Colon cancer]]‎
 
**[[Rectal cancer]]
 
 
*[[Esophageal cancer]] ‎  
 
*[[Esophageal cancer]] ‎  
 
**[[Esophageal adenocarcinoma]]
 
**[[Esophageal adenocarcinoma]]
*[[Gastric cancer]]
+
*[[Gallbladder cancer]]
*[[Hepatocellular carcinoma]] ‎  
+
*[[Gastric cancer]] ‎  
*[[Pancreatic cancer]] ‎ ‎  
+
*[[Pancreatic cancer]] ‎ ‎  
  
 
==Diseases for which it was used==
 
==Diseases for which it was used==
Line 25: Line 30:
  
 
==Patient drug information==
 
==Patient drug information==
*[https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208723s000lbl.pdf Folinic acid (Leucovorin) package insert]<ref name="insert"></ref>
+
*[https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208723s000lbl.pdf Leucovorin (Folinic acid) package insert]<ref name="insert"></ref>
*[http://chemocare.com/bio/folinic_acid.asp Folinic acid (Leucovorin) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/folinic_acid.asp Folinic acid (Leucovorin) patient drug information (Chemocare)]</ref>
+
*[http://chemocare.com/bio/folinic_acid.asp Leucovorin (Folinic acid) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/folinic_acid.asp Leucovorin (Folinic acid) patient drug information (Chemocare)]</ref>
*[http://www.uptodate.com/contents/leucovorin-patient-drug-information Folinic acid (Leucovorin) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/leucovorin-patient-drug-information Folinic acid (Leucovorin) patient drug information (UpToDate)]</ref>
+
*[http://www.uptodate.com/contents/leucovorin-patient-drug-information Leucovorin (Folinic acid) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/leucovorin-patient-drug-information Leucovorin (Folinic acid) patient drug information (UpToDate)]</ref>
  
 
==History of changes in FDA indication==
 
==History of changes in FDA indication==
* 6/20/1952: Initial FDA approval
+
* 1952-06-20: Initial FDA approval
* Indicated for use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced [[colorectal cancer]].
+
* Uncertain date: Indicated for use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced [[colorectal cancer]]. ''(Based on O'Connell 1989 & Poon et al. 1989)''
  
 
==Also known as==
 
==Also known as==
*'''Generic names:''' citrovorum factor, folinate calcium, folinato de calcio, leucovorin calcium, LV, sodium folinate
+
*'''Generic names:''' calcium folinate, citrovorum factor, folinate calcium, folinato de calcio, folinic acid, leucovorin calcium, LV, sodium folinate
 
*'''Brand names:'''
 
*'''Brand names:'''
 
{| class="wikitable" style="text-align:center;"
 
{| class="wikitable" style="text-align:center;"
Line 49: Line 54:
 
|-
 
|-
 
|Calcium Folint
 
|Calcium Folint
|Calcium Leucovorin
 
 
|Calcium Leucovorn
 
|Calcium Leucovorn
 
|Calcivoran
 
|Calcivoran
Line 56: Line 60:
 
|Calfolin
 
|Calfolin
 
|Calinat
 
|Calinat
 +
|Cehafolin
 
|-
 
|-
|Cehafolin
 
 
|Citofolin
 
|Citofolin
 
|Claro
 
|Claro
Line 65: Line 69:
 
|Divifolin
 
|Divifolin
 
|Durofolin
 
|Durofolin
 +
|Ecofol
 
|-
 
|-
|Ecofol
 
 
|Elvefocal
 
|Elvefocal
 
|Emovis
 
|Emovis
Line 74: Line 78:
 
|Fauldleuco
 
|Fauldleuco
 
|Fayining
 
|Fayining
 +
|Fedolen
 
|-
 
|-
|Fedolen
 
 
|Ferbon
 
|Ferbon
 
|Folaren
 
|Folaren
Line 83: Line 87:
 
|Folidan
 
|Folidan
 
|Folidar
 
|Folidar
 +
|Foliment
 
|-
 
|-
|Foliment
 
 
|Folinac
 
|Folinac
 
|Folinato
 
|Folinato
Line 92: Line 96:
 
|Folinvit
 
|Folinvit
 
|Foliplus
 
|Foliplus
 +
|Folmigor
 
|-
 
|-
|Folmigor
 
 
|Ifavor
 
|Ifavor
 
|Isovorin
 
|Isovorin
Line 101: Line 105:
 
|Lederfolat
 
|Lederfolat
 
|Lederfolin
 
|Lederfolin
 +
|Lederfoline
 
|-
 
|-
|Lederfoline
 
 
|Ledervorin
 
|Ledervorin
 
|Legifol
 
|Legifol
Line 108: Line 112:
 
|Leuconolver
 
|Leuconolver
 
|Leucosar
 
|Leucosar
|Leucovorin
 
 
|Leucovorina
 
|Leucovorina
|-
 
 
|Leucovorine
 
|Leucovorine
 
|Leukovorin
 
|Leukovorin
 +
|-
 
|Lovorin
 
|Lovorin
 
|Medicofolin
 
|Medicofolin
Line 119: Line 122:
 
|Neofolin
 
|Neofolin
 
|Nyrin
 
|Nyrin
|-
 
 
|O Folin
 
|O Folin
 
|Osfolate
 
|Osfolate
 +
|-
 
|Osfolato
 
|Osfolato
 
|Perfolate
 
|Perfolate
Line 128: Line 131:
 
|Recovorin
 
|Recovorin
 
|Reotan
 
|Reotan
|-
 
 
|Rescuvolin
 
|Rescuvolin
 
|Resfolin
 
|Resfolin
 +
|-
 
|Ribofolin
 
|Ribofolin
 
|Rontafor
 
|Rontafor
Line 137: Line 140:
 
|Tonofolin
 
|Tonofolin
 
|Veravorin
 
|Veravorin
|-
 
 
|Vorina
 
|Vorina
 
|Wellcovorin
 
|Wellcovorin
 +
|-
 
|Zyofolin
 
|Zyofolin
 
|Zytofolin
 
|Zytofolin
Line 153: Line 156:
 
[[Category:Chemotherapy protective agents]]
 
[[Category:Chemotherapy protective agents]]
  
 +
[[Category:Folic acid analog]]
 +
 +
[[Category:Anal cancer medications]]
 
[[Category:Cervical cancer medications]]
 
[[Category:Cervical cancer medications]]
 
[[Category:Cholangiocarcinoma medications]]
 
[[Category:Cholangiocarcinoma medications]]
Line 159: Line 165:
 
[[Category:Esophageal adenocarcinoma medications]]
 
[[Category:Esophageal adenocarcinoma medications]]
 
[[Category:Esophageal cancer medications]]
 
[[Category:Esophageal cancer medications]]
 +
[[Category:Gallbladder cancer medications]]
 
[[Category:Gastric cancer medications]]
 
[[Category:Gastric cancer medications]]
 
[[Category:Hepatocellular carcinoma medications]]
 
[[Category:Hepatocellular carcinoma medications]]

Latest revision as of 15:22, 29 September 2023

General information

Class/mechanism: Folic acid analog; counteracts the effects of folic acid antagonists such as methotrexate, which acts by inhibiting dihydrofolate reductase. Enhances the activity of Fluorouracil (5-FU) by inhibiting thymidylate synthase.[1][2]
Route: PO, IM, IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is established (work in progress)

Note: these are diseases where folinic acid is used as an adjuvant to Fluorouracil (5-FU), as opposed to an antidote as it is used in conjunction with Methotrexate (MTX)

Diseases for which it is used

Note: these are diseases where folinic acid is used as an adjuvant to Fluorouracil (5-FU), as opposed to an antidote as it is used in conjunction with Methotrexate (MTX)

Diseases for which it was used

Note: these are diseases where folinic acid is used as an adjuvant to Fluorouracil (5-FU), as opposed to an antidote as it is used in conjunction with Methotrexate (MTX)

Patient drug information

History of changes in FDA indication

  • 1952-06-20: Initial FDA approval
  • Uncertain date: Indicated for use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer. (Based on O'Connell 1989 & Poon et al. 1989)

Also known as

  • Generic names: calcium folinate, citrovorum factor, folinate calcium, folinato de calcio, folinic acid, leucovorin calcium, LV, sodium folinate
  • Brand names:
Synonyms
Antrex Asovorin Biovorin Buateron Calcifolin Calciumfolin Calciumfolinat Calcium Folinato
Calcium Folint Calcium Leucovorn Calcivoran Calc Leucovorn Calfolex Calfolin Calinat Cehafolin
Citofolin Claro Cromatonbic Folinico Dalisol Degalin Divifolin Durofolin Ecofol
Elvefocal Emovis Erbanfol Estroquin Fastovorin Fauldleuco Fayining Fedolen
Ferbon Folaren Folaxin Foliben Foli Cell Folidan Folidar Foliment
Folinac Folinato Folinfabra Folinoral Folinoxan Folinvit Foliplus Folmigor
Ifavor Isovorin Kalciumfolinat Perivita Kalsiumfolinat Kunyrin Lederfolat Lederfolin Lederfoline
Ledervorin Legifol Leucocalcin Leuconolver Leucosar Leucovorina Leucovorine Leukovorin
Lovorin Medicofolin Medifolin Medsavorina Neofolin Nyrin O Folin Osfolate
Osfolato Perfolate Prefolic Prevax Recovorin Reotan Rescuvolin Resfolin
Ribofolin Rontafor Sanifolin Tecnovorin Tonofolin Veravorin Vorina Wellcovorin
Zyofolin Zytofolin

References